Danaher Corporation $DHR Stock: Mawer Investment Management Ltd. Decreases Holdings

Mawer Investment Management Ltd. decreased its position in shares of Danaher Corporation (NYSE:DHR) by 32.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 215,153 shares of the conglomerate’s stock after selling 104,430 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Danaher were worth $47,667,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of Danaher in the 2nd quarter valued at $10,492,520,000. Jupiter Topco LLC acquired a new stake in Danaher during the 2nd quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new stake in Danaher during the 2nd quarter worth $1,287,949,000. Bank of America Corp DE acquired a new stake in Danaher during the 2nd quarter worth $993,846,000. Finally, Legal & General Group Plc purchased a new position in Danaher during the 2nd quarter worth $801,056,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR traded up $1.00 during mid-day trading on Friday, hitting $233.16. 3,359,470 shares of the company were exchanged, compared to its average volume of 4,152,061. The stock has a 50 day simple moving average of $222.56 and a 200-day simple moving average of $201.52. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The firm has a market cap of $164.04 billion, a price-to-earnings ratio of 38.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.76.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analysts’ expectations of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher’s revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.89 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.

Analysts Set New Price Targets

A number of research firms have commented on DHR. Barclays lifted their price objective on shares of Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Robert W. Baird increased their target price on shares of Danaher from $246.00 to $254.00 and gave the stock an “outperform” rating in a research note on Thursday, October 22nd. Guggenheim raised their price target on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Monday, October 26th. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president owned 22,367 shares in the company, valued at $5,158,277.54. This trade represents a 8.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 10.80% of the company’s stock.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.